Overcoming delivery barriers with LNPs

被引:21
作者
Jadhav, Satish G. [1 ]
Dowdy, Steven F. [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
关键词
LIPID NANOPARTICLES;
D O I
10.1038/s41563-021-00988-3
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Ionizable phospholipids have been developed to enhance the delivery of mRNA and sgRNA for gene editing by selective organ targeting and endosomal membrane destabilization.
引用
收藏
页码:575 / 577
页数:3
相关论文
共 50 条
[31]   Overcoming barriers in cystic fibrosis therapy through inhalational lipid nanoparticles: Challenges and advances [J].
Anjum, Md Meraj ;
Patel, Krishna Kumar ;
Bhattacharya, Sankha ;
Arya, Dilip Kumar ;
Pandey, Prashant ;
Vijayakumar, M. R. ;
Singh, Sanjay ;
Rajinikanth, Paruvathanahalli Siddalingam .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 89
[32]   A preparation method for mRNA-LNPs with improved properties [J].
Geng, Cong ;
Zhou, Kefan ;
Yan, Ying ;
Li, Chan ;
Ni, Beibei ;
Liu, Jiangman ;
Wang, Yeming ;
Zhang, Xiaoyan ;
Wang, Dazhuang ;
Lv, Lu ;
Zhou, Yongchuan ;
Feng, Anhua ;
Wang, Yajuan ;
Li, Chunlei .
JOURNAL OF CONTROLLED RELEASE, 2023, 364 :632-643
[33]   siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases [J].
Kalita, Tutu ;
Dezfouli, Saba Abbasi ;
Pandey, Lalit M. ;
Uludag, Hasan .
PHARMACEUTICS, 2022, 14 (11)
[34]   Post-encapsulation methods for the preparation of mRNA-LNPs [J].
Duffrene, Joanna ;
Muzard, Chloe ;
Seguin, Johanne ;
Izabelle, Charlotte ;
Vrai, Thibaut ;
Ejlalmanesh, Tina ;
Bombled, Marianne ;
Hamdi, Samir ;
Lemdani, Katia ;
Alhareth, Khair ;
Mignet, Nathalie .
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2025,
[35]   DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine/drug delivery [J].
Nag, Kakon ;
Sarker, Md Enamul Haq ;
Kumar, Samir ;
Khan, Habiba ;
Chakraborty, Sourav ;
Islam, Md Jikrul ;
Baray, Juwel Chandra ;
Khan, Maksudur Rahman ;
Mahmud, Asif ;
Barman, Uttam ;
Bhuiya, Eleus Hussain ;
Mohiuddin, Mohammad ;
Sultana, Naznin .
SCIENTIFIC REPORTS, 2022, 12 (01)
[36]   Antitumor Activity of G3139 Lipid Nanoparticles (LNPs) [J].
Pan, Xiaogang ;
Chen, Li ;
Liu, Shujun ;
Yang, Xiaojuan ;
Gao, Jian-Xin ;
Lee, Robert J. .
MOLECULAR PHARMACEUTICS, 2009, 6 (01) :211-220
[37]   Breaking barriers in ocular drug delivery for Uveitis: Advanced drug delivery systems, challenges and future prospects [J].
Ambekar, Anju ;
Sahoo, Jagannath ;
Singh, Kavita .
EXPERIMENTAL EYE RESEARCH, 2025, 257
[38]   Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance [J].
Muraoka, Daisuke ;
Harada, Naozumi ;
Shiku, Hiroshi ;
Akiyoshi, Kazunari .
JOURNAL OF CONTROLLED RELEASE, 2022, 347 :175-182
[39]   Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines [J].
Lutz, Johannes ;
Lazzaro, Sandra ;
Habbeddine, Mohamed ;
Schmidt, Kim Ellen ;
Baumhof, Patrick ;
Mui, Barbara L. ;
Tam, Ying K. ;
Madden, Thomas D. ;
Hope, Michael J. ;
Heidenreich, Regina ;
Fotin-Mleczek, Mariola .
NPJ VACCINES, 2017, 2
[40]   PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs [J].
Wong, Patty ;
Li, Lin ;
Chea, Junie ;
Delgado, Melissa K. ;
Crow, Desiree ;
Poku, Erasmus ;
Szpikowska, Barbara ;
Bowles, Nicole ;
Channappa, Divya ;
Colcher, David ;
Wong, Jeffrey Y. C. ;
Shively, John E. ;
Yazaki, Paul J. .
NUCLEAR MEDICINE AND BIOLOGY, 2017, 47 :62-68